More than three years after approving two biosimilars referencing Sanofi’s long-acting insulin Lantus, the FDA has signed off on a rapid-acting insulin biosimilar for the first time. The agency ...
WAGM-TV on MSN6d
Attorney General Aaron M. Frey Announces Settlement Agreement Will Bring $35 Insulin to MainersAttorney General Aaron M. Frey announced a settlement agreement with Sanofi-Aventis U.S. LLC after scrutiny over the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback